CalciMedica, Inc.

CALC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $18.6M $8.2M $11.5M $5.5M $5.9M $12.6M $7.9M $9.2M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $19.5M $8.6M $13.5M $14.9M $19.0M $25.2M $19.7M $15.7M
Property, Plant & Equipment $36.0K $43.0K $50.0K $49.0K $105.0K $118.0K $119.0K $130.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $19.5M $8.6M $13.6M $14.9M $19.1M $25.3M $19.8M $16.2M
Liabilities
Accounts Payable $2.1M $1.7M $1.2M $1.1M $1.9M $2.0M $2.0M $1.5M
Total Current Liabilities $3.5M $5.3M $3.8M $3.7M $3.5M $4.5M $3.7M $3.8M
Long-Term Debt — — — — — — — —
Total Liabilities $14.0M $9.7M $20.2M $15.2M $13.0M $14.5M $5.4M $7.2M
Stockholders' Equity
Retained Earnings $-192.0M $-184.4M $-189.3M $-178.6M $-170.8M $-164.8M $-159.8M $-155.5M
Total Stockholders' Equity $5.5M $-1.1M $-6.6M $-268.0K $6.1M $10.9M $14.4M $9.0M
← Newer Page 1 of 4 Older →